Granite Harbor Advisors’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
Other funds holding EW
WT
BHIA
NONA
SIM
Granite Harbor Advisors's EW Position: Q2 2026 in Review
Granite Harbor Advisors reduced its Edwards Lifesciences (EW) stake by 0.64% in Q2 2026, selling an estimated $2.43K and leaving 4,488 shares worth $406K. The position accounts for 0.16% of the portfolio, ranked #92.
Granite Harbor Advisors first reported a position in EW in Q4 2022 and has held it in 15 quarters since. The position peaked at $411K in Q4 2025. 563 funds tracked by Wall St. Rank hold EW as of Q2 2026.
- Granite Harbor Advisors held 4,488 shares of Edwards Lifesciences worth $406K as of Q2 2026.
- Granite Harbor Advisors sold 29 Edwards Lifesciences shares in Q2 2026, an estimated $2.43K.
- Edwards Lifesciences made up 0.16% of Granite Harbor Advisors's portfolio in Q2 2026, its #92 holding.
- Granite Harbor Advisors first reported a position in Edwards Lifesciences in Q4 2022 and has held it in 15 quarters since.
- Granite Harbor Advisors's Edwards Lifesciences position peaked at $411K in Q4 2025.
- 563 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.
Based on Granite Harbor Advisors's 13F filing for Q2 2026, filed 31 Jul 2026.